A007370 Stock Overview
Engages in the pharmaceutical business in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Jin Yang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,000.00 |
| 52 Week High | ₩8,100.00 |
| 52 Week Low | ₩4,860.00 |
| Beta | -0.23 |
| 11 Month Change | 4.53% |
| 3 Month Change | -0.66% |
| 1 Year Change | -2.76% |
| 33 Year Change | -10.71% |
| 5 Year Change | 51.13% |
| Change since IPO | 202.42% |
Recent News & Updates
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth
Aug 19
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12Recent updates
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth
Aug 19These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well
Aug 12Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit
May 23A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
Mar 22Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock
Mar 04These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely
Feb 11
Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 21Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?
Jan 04We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings
Dec 17Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching
Nov 30Shareholder Returns
| A007370 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 11.5% | -6.3% | -0.7% |
| 1Y | -2.8% | 5.5% | -4.1% |
Return vs Industry: A007370 underperformed the KR Pharmaceuticals industry which returned 5.5% over the past year.
Return vs Market: A007370 exceeded the KR Market which returned -4.1% over the past year.
Price Volatility
| A007370 volatility | |
|---|---|
| A007370 Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A007370 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A007370's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | n/a | Choi Hwan | www.jinyangpharm.com |
Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers products for anti-diabetics, antivirals, anti-hypertensives, anti-coagulants, antihistamines, antipyretics, and analgesics; digestive, respiratory, and neuropsychiatric system. It also provides drugs for genito-urinary system, anti-osteoporosis drugs, antimicrobials and antibiotics; and over the counter drugs antipyretics and analgesics.
Jin Yang Pharmaceutical Co., Ltd. Fundamentals Summary
| A007370 fundamental statistics | |
|---|---|
| Market cap | ₩67.42b |
| Earnings (TTM) | ₩28.13b |
| Revenue (TTM) | ₩111.15b |
2.4x
P/E Ratio0.6x
P/S RatioIs A007370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007370 income statement (TTM) | |
|---|---|
| Revenue | ₩111.15b |
| Cost of Revenue | ₩42.92b |
| Gross Profit | ₩68.23b |
| Other Expenses | ₩40.10b |
| Earnings | ₩28.13b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.46k |
| Gross Margin | 61.39% |
| Net Profit Margin | 25.31% |
| Debt/Equity Ratio | 72.5% |
How did A007370 perform over the long term?
See historical performance and comparison